TP53 and liver cancer: Subsequent to the inflammatory response, 12–48% of liver cancers exhibit mutations in the TP53 gene or a disruption of the p53 signaling pathway [20] leading to poorly differentiated tumors and distinct gene expression profiles, which are linked to stemness [21].